Target intelligence / Profile preview

Host cell membrane entry receptors

Molecular classification
Receptor, Glycoprotein, Membrane protein, Cell adhesion molecule, Enzyme
01

Overview

Host cell membrane entry receptors are a broad class of surface molecules, including proteins, glycoproteins, and carbohydrates, that pathogens exploit to gain access to the intracellular environment. These receptors typically perform vital physiological functions, such as serving as chemokine receptors (e.g., CCR5), enzymes (e.g., ACE2), or adhesion molecules (e.g., ICAM-1), but are hijacked by viruses and bacteria through high-affinity interactions with pathogen-encoded ligands (Maginnis, 2018, Encyclopedia of Virology). For example, the SARS-CoV-2 spike protein binds to Angiotensin-converting enzyme 2 (ACE2) to trigger membrane fusion (Hoffmann et al., 2020, Cell), while HIV-1 utilizes CD4 and coreceptors like CCR5 or CXCR4 for entry (NIH, 2023). Therapeutic strategies targeting these host factors, such as the CCR5 antagonist Maraviroc, aim to block the initial stages of the infection cycle (Dorr et al., 2005, Antimicrob Agents Chemother). While host-targeted entry inhibitors can provide a high genetic barrier to pathogen resistance, they also carry risks of interfering with the receptor's endogenous biological roles, potentially leading to adverse effects or altered immune responses.

Other names
Viral entry receptorsPathogen entry receptorsHost cell surface receptorsAttachment factors
02

Mechanism of action

Inhibition of pathogen attachment, fusion, or entry by binding to host cell surface molecules and blocking interaction with pathogen ligands.

03

Biological functions

Signal transductionCell-cell adhesionEndocytosisIon transportImmune responseCellular homeostasis
04

Disease associations

InfectionViral infection (e.g., HIV, COVID-19, Ebola)Bacterial infectionParasitic infection
05

Safety considerations

Interference with physiological ligand binding and signalingPotential for immunosuppressionOff-target effects on cellular homeostasisPathogen adaptation to alternative entry pathways
06

Interacting drugs

Maraviroc

4 more in the full profile.

07

Biomarkers

CCR5 tropism (e.g., Trofile assay)Cluster of differentiation 4 (CD4) T-cell countAngiotensin-converting enzyme 2 (ACE2) expression levelsGenetic polymorphisms (e.g., CCR5-delta32 mutation)

Beyond the preview

Go deeper on Host cell membrane entry receptors.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Host cell membrane entry receptors.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call